Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole

[1]  E. Werner,et al.  Synthesis and characterization of 3H-labelled tetrahydrobiopterin. , 1994, The Biochemical journal.

[2]  P. Klatt,et al.  Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells. , 1994, The Biochemical journal.

[3]  E. Werner,et al.  The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. , 1994, The Journal of biological chemistry.

[4]  E. Kandel,et al.  Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation , 1994, Nature.

[5]  P. Klatt,et al.  Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation. , 1994, The Journal of biological chemistry.

[6]  P. Klatt,et al.  Reversible inactivation of endothelial nitric oxide synthase by N G‐nitro‐l‐arginine , 1993, FEBS letters.

[7]  K. Baek,et al.  Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. , 1993, The Journal of biological chemistry.

[8]  G. Böhme,et al.  Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Masters,et al.  Optical difference spectrophotometry as a probe of rat brain nitric oxide synthase heme-substrate interaction. , 1993, Biochemistry.

[10]  S. L. Hart,et al.  Characterization of the novel nitric oxide synthase inhibitor 7‐nitro indazole and related indazoles: antinociceptive and cardiovascular effects , 1993, British journal of pharmacology.

[11]  S. L. Hart,et al.  Inhibition of rat cerebellar nitric oxide synthase by 7‐nitro indazole and related substituted indazoles , 1993, British journal of pharmacology.

[12]  J. Boucher,et al.  EPR characterization of molecular targets for NO in mammalian cells and organelles , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Klatt,et al.  Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate. , 1993, The Journal of biological chemistry.

[14]  M. Marletta,et al.  Nitric oxide synthase structure and mechanism. , 1993, The Journal of biological chemistry.

[15]  B. Mayer.  Molecular characteristics and enzymology of nitric oxide synthase and soluble guanylyl cyclase in the CNS , 1993 .

[16]  A. Michel,et al.  Characterization of the binding of [3H]‐l‐NG‐nitro‐arginine in rat brain , 1993, British journal of pharmacology.

[17]  D. J. Wolff,et al.  Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. , 1993, The Journal of biological chemistry.

[18]  S. L. Hart,et al.  7‐Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti‐nociceptive activity in the mouse without increasing blood pressure , 1993, British journal of pharmacology.

[19]  B. Mayer,et al.  Inhibition of nitric oxide synthesis by methylene blue. , 1993, Biochemical pharmacology.

[20]  S. Snyder,et al.  Generation of superoxide by purified brain nitric oxide synthase. , 1992, The Journal of biological chemistry.

[21]  H. Kaube,et al.  Nitric oxide synthesis couples cerebral blood flow and metabolism , 1992, Brain Research.

[22]  P. Klatt,et al.  Ca2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. , 1992, The Journal of biological chemistry.

[23]  P. Klatt,et al.  Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. , 1992, The Biochemical journal.

[24]  D. Madison,et al.  A requirement for the intercellular messenger nitric oxide in long-term potentiation. , 1991, Science.

[25]  F. Murad,et al.  Characterization of nitric oxide synthases in non‐adrenergic non‐cholinergic nerve containing tissue from the rat anococcygeus muscle , 1991, British journal of pharmacology.

[26]  H Wachter,et al.  Brain nitric oxide synthase is a biopterin‐ and flavin‐containing multi‐functional oxido‐reductase , 1991, FEBS letters.

[27]  G. Böhme,et al.  Possible involvement of nitric oxide in long-term potentiation. , 1991, European journal of pharmacology.

[28]  J. Garthwaite.  Glutamate, nitric oxide and cell-cell signalling in the nervous system , 1991, Trends in Neurosciences.

[29]  W. Kukovetz,et al.  Radioligand binding to muscarinic receptors of bovine aortic endothelial cells , 1991, British journal of pharmacology.

[30]  B. Mayer,et al.  Purification of a Ca2+/calmodulin‐dependent nitric oxide synthase from porcine cerebellum , 1990, FEBS letters.

[31]  S. Snyder,et al.  Localization of nitric oxide synthase indicating a neural role for nitric oxide , 1990, Nature.

[32]  G. Boeckxstaens,et al.  Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter , 1990, Nature.

[33]  J. Garthwaite,et al.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.

[34]  J. Steinmetz,et al.  Inhibition of nitric oxide synthesis impairs two different forms of learning. , 1992, Neuroreport.

[35]  U Walter,et al.  Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. , 1989, Reviews of physiology, biochemistry and pharmacology.

[36]  R. D. Levie,et al.  When, why, and how to use weighted least squares , 1986 .